Table 1.
Animal model | Effect on atherosclerosis |
Observed atherosclerotic characteristics | References |
---|---|---|---|
KLF2+/−; ApoE−/− mice | ↑ | ↑ Foam cell formation | [36] |
KLF2 ΔMye; LDLR−/− mice | ↑ | ↑ Lesional neutrophils and macrophages | [38] |
KLF4 ΔEC; ApoE−/− | ↑ | ↑ Endothelial inflammation and thrombosis | [35] |
KLF4Tg(EC); ApoE−/− | ↓ | ↓ Endothelial inflammation and thrombosis | [35] |
NRF2−/−; ApoE−/− | ↓ | ↓ Foam cell formation | [95, 96] |
NRF2−/−; LDLR−/− ApoB 100/100 | Mixed |
↓ Atherosclerotic lesion size ↑ Atherosclerotic plaque vulnerability |
[97] |
NF-kBΔEC; ApoE−/− | ↓ | ↓ Adhesion molecules and inflammation | [63] |
I-κBmtOE(EC); ApoE−/− | ↓ | ↓ Chronic intermittent hypoxia induced atherosclerosis; NF-kB activity | [64] |
HIF-1αΔEC; ApoE−/− | ↓ | ↓ Monocyte adhesion | [61] |
HIF-1αΔMye; ApoE−/− | ↓ | ↓ Inflammatory gene expression | [98] |
YAP/TAZKD; ApoE−/− | ↓ | ↓ Promotes EC proliferation, inflammation | [27] |
YAPOE (EO); ApoE−/−; YAPTg (EC); ApoE−/−; YAP/TAZCA; ApoE−/− | ↑ | ↑ Monocyte adhesion, macrophage accumulation | [26] |
YApOE (EC); ApoE−/− | ↑ | ↑ VCAM1 dependent monocyte adhesion | [28] |
Abbreviations:
KD, knockdown; OE (EC), endothelial cell-specific overexpression; Tg (EC), endothelial cell specific transgene; ΔMye, myeloid cell-specific knockout; ΔEC, endothelial cell-specific knockout